A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of pharmacokinetics and pharmacodynamics"
DOI: 10.1007/s10928-021-09789-2
Abstract: Clinical trials in patients with ulcerative colitis (UC) face the challenge of high and variable placebo response rates. The Mayo Clinical Score (MCS) is used widely as the primary endpoint in clinical trials to describe… read more here.
Keywords: mayo clinical; clinical score; ulcerative colitis; patients ulcerative ... See more keywords